AMW GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AMW GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11177
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable subcutaneous implants for the treatment of various hormone responding tumors, chronic pain and psychiatric diseases. Its products for licensing include Goserelin implant, Leuprorelin implant, Buprenorphin patch and Rivastigmin patch. AMW offers development partnerships with open and transparent collaboration with licensees for exclusive products. The company develops patented technologies for the active control of drug releasing pharmaceuticals. AMW is headquartered in Warngau, Germany.

AMW GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
Private Equity 17
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH – Key Competitors 19
AMW GmbH – Key Employees 20
AMW GmbH – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Government and Public Interest 22
Dec 21, 2017: Investment Plan for Europe: EIB grants financing to pharmaceutical company AMW 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
AMW GmbH, Pharmaceuticals & Healthcare, Key Facts 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AMW GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AMW Receives USD29.6 Million of Financing 11
AMW Raises USD6.4 Million in Venture Financing 12
AMW Raises USD9 Million in Venture Financing 13
AMW Raises Funds in Venture Financing 15
AMW Raises Funds in Third Round of Financing 16
AMW to Sell Shares to Hybio Pharma and YF Capital Led Consortium 17
AMW GmbH, Key Competitors 19
AMW GmbH, Key Employees 20

List of Figures
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AMW GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AMW GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AMW GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AMW GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • D.R. Horton Inc:戦略・SWOT・企業財務分析
    D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Salt River Project:企業の戦略・SWOT・財務分析
    Salt River Project - Strategy, SWOT and Corporate Finance Report Summary Salt River Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Accelovance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization's CRO services inc …
  • Rumex International Co:製品パイプライン分析
    Summary Rumex International Co (Rumex International) is a medical device company that manufactures and markets precision instruments for ophthalmology and cardiovascular surgery. The company provides products, which include blade holders, forceps, glaucoma instruments, hooks, lasik and lasek instrum …
  • The Swatch Group Ltd (UHR):企業の財務・戦略的SWOT分析
    The Swatch Group Ltd (UHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • RSA Insurance Group plc:企業の戦略・SWOT・財務情報
    RSA Insurance Group plc - Strategy, SWOT and Corporate Finance Report Summary RSA Insurance Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sarepta Therapeutics Inc (SRPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sarepta Therapeutics Inc (Sarepta) is discovers and develops unique RNA-targeted therapeutics, gene therapy and other genetic medicine approaches to treat rare neuromuscular diseases. The company develops drugs based on its proprietary, highly-differentiated and innovative platform technolog …
  • Scotiabank Peru S.A.A.:企業の戦略・SWOT・財務分析
    Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Abengoa, S.A.:企業の戦略・SWOT・財務情報
    Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report Summary Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務情報
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • United Biscuits (UK) Ltd:企業の戦略・SWOT・財務分析
    United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Town Centre Securities Plc:企業の戦略・SWOT・財務情報
    Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report Summary Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Selvita SA (SLV):企業の財務・戦略的SWOT分析
    Summary Selvita SA (Selvita) is a clinical stage biopharmaceutical company that develops small molecule therapies for the treatment of cancer. It is evaluating its pipeline candidates including SEL120, a selective CDK8 kinase inhibitor for the treatment of hematological malignancies and solid tumors …
  • IFFCO-Tokio General Insurance Co Ltd:企業の戦略・SWOT・財務分析
    IFFCO-Tokio General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IFFCO-Tokio General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • General Re Corporation:企業の戦略・SWOT・財務分析
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • LG Chem Ltd (051910):電力:M&Aディール及び事業提携情報
    Summary LG Chem Ltd (LG Chem) is a chemical manufacturer. It manufactures and markets petrochemicals, IT and electronic materials, and energy solutions. The company’s product portfolio comprises poly vinyl chloride (PVC), ethylene, propylene, butadiene, benzene, polarizer, glass substrate, semicondu …
  • Caltex Australia Ltd (CTX):石油・ガス:M&Aディール及び事業提携情報
    Summary Caltex Australia Ltd (Caltex) is a supplier of transport fuels and convenience retailer. The company purchases, refines, distributes and markets petroleum products. It supplies liquefied petroleum gas (LPG), petrol, diesel, jet fuel, lubricants, greases, fuel oil and specialty products. The …
  • GWA Group Limited (GWA):企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆